|
|
Effect comparison of Rosuvastatin Calcium and Simvastatin in the treatment of hyperlipidemia complicated with hypertension |
ZHANG Yuan-sheng1 GONG De-xiang2 WU Hui-jing2 |
1.Department of Emergency,the Fourth People′s Hospital of Longgang District in Shenzhen City,Guangdong Province,Shenzhen 518114,China;2.Department of Internal Medicine,the Fourth People′s Hospital of Longgang District in Shenzhen City,Guangdong Province,Shenzhen 518114,China |
|
|
Abstract ObjectiveTo compare the efficacy of Rosuvastatin Calcium or Simvastatin in patients with hyperlipidemia and hypertension.MethodsA total of 200 patients with hyperlipidemia complicated with hypertension treated in our hospital from May 1,2016 to May 1,2017 were selected as subjects.They were equally divided into two groups based on the random number table method,100 cases in each group.The control group was treated with Simvastatin and the observation group was treated Rosuvastatin Calcium.The indexe of blood lipidsare was described in the following aspects of total cholesterol(TC),triglyceride(TG),low-density lipoprotein cholesterol(LDL-C),high density lipoprotein cholesterol(HDL-C),and blood pressure indexes included systolic and diastolic blood pressures were compared between the two groups.ResultsAfter treatment,the TC,TG and LDL-C in the observation group were (4.16±0.36)mmol/L,(1.61±0.28)mmol/L and (2.27±0.41)mmol/L,which were all lower than those of the control group of(5.75±0.51)mmol/L,(2.41±0.29)mmol/L and(3.26±0.38)mmol/L,while the HDL-C in the observation group was(1.52±0.31)mmol/L,which was higher than that in the control group of(1.25±0.34)mmol/L with significance differences (P<0.05).The systolic blood pressure and diastolic blood pressure were (120.62±8.48)mmHg and (80.46±4.26)mmHg in the observation group,which were lower than those in the control group of(138.29±12.05)mmHg and(89.62±5.18)mmHg,with statistical significance differences(P<0.05).ConclusionFor patients with hyperlipidemia and hypertension,Resuvastatin Calcium therapy is more effective than Simvastatin.
|
|
|
|
|
[1] |
罗爱国.高脂血症合并高血压采用瑞舒伐他汀钙与阿托伐他汀钙治疗的临床效果报道[J].数理医药学杂志,2016,29(7):1048-1050.
|
[2] |
冯美杰.不同剂量辛伐他汀治疗老年高脂血症疗效对比[J].中国老年学杂志,2013,33(1):201-202.
|
[3] |
魏桂红.苯磺酸左旋氨氯地平和瑞舒伐他汀钙片对高血压病合并高脂血症患者临床疗效分析[J].临床和实验医学杂志,2013,12(7):550-551.
|
[4] |
赵国强.瑞舒伐他汀钙或阿托伐他汀钙联合氨氯地平在高脂血症合并高血压治疗中的效果[J].中西医结合心血管病电子杂志,2017,5(24):91.
|
[5] |
叶子思,黄正有,戴德栋,等.不同剂量辛伐他汀治疗老年高血压合并高脂血症的临床疗效及安全性探讨[J].当代医学,2011,17(34):133-135.
|
[6] |
童程程,唐海沁,李瑾,等.依折麦布联合辛伐他汀降脂疗效和安全性的Meta分析[J].中国循证心血管医学杂志,2013,5(2):116-120.
|
[7] |
胡四海.辛伐他汀治疗高血压合并高血脂患者的临床疗效及其对血清超敏C反应蛋白的影响[J].实用临床医药杂志,2015,19(9):127-128.
|
[8] |
袁前发,唐思梦,陈思羽,等.黄芪多糖与辛伐他汀对高脂血症大鼠治疗效果的动态对比研究 [J].中国医药导报,2017,14(23):8-12.
|
[9] |
曲莲莲,陶晶晶,代雅琪,等.银丹心脑通联合瑞舒伐他汀钙对冠心病伴高脂血症患者的疗效[J].西北药学杂志,2017,32(6):775-779.
|
[10] |
王慧君,吕正梅,戎玉罗,等.高脂血症对小鼠睾丸StAR和P450 scc表达的影响及辛伐他汀的干预作用[J].安徽医科大学学报,2014,12(6):711-714,720.
|
[11] |
蒋丽,覃香,赖呈谋,等.瑞舒伐他汀与辛伐他汀治疗高脂血症临床疗效比较[J].海南医学,2017,28(9):1406-1408.
|
[12] |
张小敏,王福安,张宇,等.依折麦布联合辛伐他汀治疗膜性肾病合并高脂血症的临床观察[J].中国药房,2016,27(23):3273-3275.
|
[13] |
钱志芳,张波.阿托伐他汀钙与辛伐他汀治疗原发性高脂血症临床随机对照研究[J].中国药业,2017,26(7):49-52.
|
[14] |
马会军,牛芳桥.瑞舒伐他汀治疗高脂血症的疗效及其对颈动脉粥样硬化斑块的影响[J].实用临床医药杂志,2013,17(14):5-7,13.
|
[15] |
徐惠,崔飞飞.瑞舒伐他汀、辛伐他汀治疗高脂血症伴发冠心病疗效对比观察[J].山东医药,2013,53(48):38-40.
|
|
|
|